Diaceutics PLC
DXRX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £13 | £17 | £20 | £20 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £15 | £10 | £10 | £10 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £2 | £1 | £1 | £0 |
| Total Curr. Assets | £30 | £28 | £31 | £30 |
| Property Plant & Equip (Net) | £2 | £2 | £2 | £2 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £15 | £15 | £15 | £13 |
| Long-Term Investments | £0 | -£15 | £17 | £15 |
| Tax Assets | £2 | £1 | £0 | £0 |
| Other NC Assets | £0 | £15 | -£17 | -£15 |
| Total NC Assets | £19 | £18 | £17 | £15 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £49 | £46 | £48 | £45 |
| Liabilities | – | – | – | – |
| Payables | £1 | £1 | £1 | £1 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £6 | £2 | £2 | £2 |
| Total Curr. Liab. | £8 | £4 | £4 | £3 |
| LT Debt | £1 | £1 | £1 | £1 |
| Deferred Rev, NC | £0 | £0 | £0 | -£0 |
| Deferred Tax Liab, NC | £0 | £0 | £1 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £1 | £1 | £2 | £2 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £1 | £1 | £1 | £1 |
| Total Liabilities | £9 | £6 | £6 | £4 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £0 | £0 | £0 | £0 |
| Retained Earnings | £41 | £4 | £5 | £4 |
| AOCI | -£1 | -£0 | £0 | -£0 |
| Other Equity | -£0 | £37 | £37 | £37 |
| Total Equity | £40 | £41 | £43 | £41 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £49 | £46 | £48 | £45 |
| Net Debt | -£12 | -£15 | -£18 | -£18 |